CAMBRIDGE, Mass.--(BUSINESS WIRE)--Parallel Bio, a biotech company pioneering human-first drug discovery, today announced it has raised $21 million Series A funding, led by AIX Ventures. The round ...
Abstract: Existing CPU scaling approaches have limitations that can lead to inefficient resource allocation and increased penalty costs for tasks with soft deadlines running in container clouds. First ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results